Skip to main content
Signal8

Unicycive Therapeutics, Inc. (UNCY) AI Dilution Summary

Updated Nov 16, 2026

Cash was $41,966,000 at the 2026-09-30 balance-sheet date, against estimated monthly burn of $2,416,333. The company is funding itself through an active ATM program with Guggenheim Securities, LLC, authorised to $150,000,000. That program has sold $43,500,000 and 8,785,514 shares since it began, through 2025-11-14.